TY - JOUR
T1 - Accounting for variation in and overuse of antibiotics among humans
AU - Blaser, Martin J.
AU - Melby, Melissa K.
AU - Lock, Margaret
AU - Nichter, Mark
N1 - Funding Information:
Supported in part by CIFAR (Humans and Microbiome Program), U01 AI22285 from the National Institutes of Health, Transatlantic Program of Fondation Leducq, and the Zlinkoff and C & D funds. The authors thank Kryst Cedeno for her editorial assistance and Nafade Vaidehe for her initial contributions to the research.
Publisher Copyright:
© 2021 Wiley Periodicals LLC
PY - 2021/2
Y1 - 2021/2
N2 - Worldwide, antibiotic use is increasing, but many infections against which antibiotics are applied are not even caused by bacteria. Over-the-counter and internet sales preclude physician oversight. Regional differences, between and within countries highlight many potential factors influencing antibiotic use. Taking a systems perspective that considers pharmaceutical commodity chains, we examine antibiotic overuse from the vantage point of both sides of the therapeutic relationship. We examine patterns and expectations of practitioners and patients, institutional policies and pressures, the business strategies of pharmaceutical companies and distributors, and cultural drivers of variation. Solutions to improve antibiotic stewardship include practitioners taking greater responsibility for their antibiotic prescribing, increasing the role of caregivers as diagnosticians rather than medicine providers, improving their communication to patients about antibiotic treatment consequences, lessening the economic influences on prescribing, and identifying antibiotic alternatives.
AB - Worldwide, antibiotic use is increasing, but many infections against which antibiotics are applied are not even caused by bacteria. Over-the-counter and internet sales preclude physician oversight. Regional differences, between and within countries highlight many potential factors influencing antibiotic use. Taking a systems perspective that considers pharmaceutical commodity chains, we examine antibiotic overuse from the vantage point of both sides of the therapeutic relationship. We examine patterns and expectations of practitioners and patients, institutional policies and pressures, the business strategies of pharmaceutical companies and distributors, and cultural drivers of variation. Solutions to improve antibiotic stewardship include practitioners taking greater responsibility for their antibiotic prescribing, increasing the role of caregivers as diagnosticians rather than medicine providers, improving their communication to patients about antibiotic treatment consequences, lessening the economic influences on prescribing, and identifying antibiotic alternatives.
UR - http://www.scopus.com/inward/record.url?scp=85099016363&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85099016363&partnerID=8YFLogxK
U2 - 10.1002/bies.202000163
DO - 10.1002/bies.202000163
M3 - Article
C2 - 33410142
AN - SCOPUS:85099016363
SN - 0265-9247
VL - 43
JO - BioEssays
JF - BioEssays
IS - 2
M1 - 2000163
ER -